Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (14)
  1. 5. Schneider, E. M., Farber, C., Struelens, M., & Van Vooren, J.-P. (1997). Long survival of a patient with AIDS in spite of previous Rhodococcus equi infection [2]. Acta clinica Belgica (Ed. multilingue), 52(1), 50.
  2. 6. Simonart, T., Noël, J. C., Liesnard, C., Parent, D., Heenen, M., Brancart, F., Van Vooren, J.-P., Farber, C., Blankaert, D., & Werenne, J. (1996). Kaposi's sarcoma and herpesvirus 8: A word of caution [4]. Dermatology, 193(3), 272.
  3. 7. Farber, C., Barath, A., Dieye, T., Kroon, F., Van Furth, R., Bruisten, S. S., Stanley, S. S., Ostrowski, M. M., & Fauci, A. A. (1996). The effects of immunization in human immunodeficiency virus type 1 infection [1]. The New England journal of medicine, 335(11), 817-819. doi:10.1056/NEJM199609123351111
  4. 8. Delpire, P., Farber, C., Portaels, F., Struelens, M., Clevenbergh, P., Dargent, J.-L., Delpace, J., Mehdi, A. I., & Van Vooren, J.-P. (1996). Splenectomy in a patients with AIDS, generalized Mycobacterium genavense infection and severe pancytopenia [1]. Tubercle and Lung Disease, 77(6), 569-570. doi:10.1016/S0962-8479(96)90059-3
  5. 9. Van Vooren, J.-P., Renard, M., Dargent, J.-L., Capel, P., Feremans, W., & Farber, C. (1995). Cardiac tamponade: The first manifestation of a generalized lymphoma in a patient with HIV infection. European journal of haematology, 55(4), 274. doi:10.1111/j.1600-0609.1995.tb00275.x
  6. 10. Delforge, M.-L., Liesnard, C., Debaisieux, L., Tchetcheroff, M., Farber, C., & Van Vooren, J.-P. (1995). In vivo inhibition of syncytium-inducing variants of HIV in patients treated with didanosine [1]. AIDS, 9(1), 89-90.
  7. 11. Michils, A., Farber, C., Van Vooren, J.-P., Yernault, J. C., & Duchateau, J. (1994). Sustained benefit of interferon-alpha therapy and oral hyposensitization in severe atopic dermatitis [9]. British journal of dermatology, 130(1), 134-135. doi:10.1111/j.1365-2133.1994.tb06908.x
  8. 12. Colebunders, R., Kintin, D., Fleerackers, Y., Demeulenaere, T., Vandenbruaene, M., Goeman, J., Kestens, L., Farber, C., & Soete, F. (1993). Surveillance case definition for AIDS in resource-poor countries. Lancet, 342(8875), 864-865. doi:10.1016/0140-6736(93)92723-7
  9. 13. Farber, C., Gourdin, A., Lambermont, M., Gilbert, C., & Van Vooren, J.-P. (1992). Substitution therapy for C1 esterase deficiency [ 3]. Lancet, 339(8785), 119.
  10. 14. Ventura, M. G., Wybran, J., & Farber, C. (1989). Sulfadiazine revisited. The Journal of infectious diseases, 160(3), 556- 557.
    11.   Participations à des congrès et colloques internationaux (21)
  11. 1. Lesage, B., Emiliani, S., Vannin, A.-S., Delbaere, A., Van Vooren, J.-P., Farber, C., Englert, Y., & Liesnard, C. (2004). Is it usefull to test the final preparation after sperm washing?: Results from a highly reliable viral validation protocol of HIV processed semen by (RT)-nested PCR. Paper session presented at International Serono Symposia on « HIV and Women’s Health » (April 2-3/2004: Los Angeles, USA).
  12. 2. Englert, Y., Lesage, B., Vannin, A.-S., Emiliani, S., Devreker, F., Place, I., Farber, C., Kirkpatrick, C., Van Vooren, J.-P., & Liesnard, C. (2003). ART in HIV infected couples: ethical grounds and clinical management. Paper session presented at 4ème Congrès on Controversies in obstetrics, gynecology and Infertility (2003: Berlin).
    13. << Précédent 1 2 3 4 5 6 7 8 Suivant >>